Generation of gene-modified T cells reactive against the angiogenic kinase insert domain-containing receptor (KDR) found on tumor vasculature

Human Gene Therapy

Volumn 11, Issue 18, 2000, Pages 2445-2452

  Kershaw, M H ^a   Westwood, J A ^a   Zhu, Z ^b   Witte, L ^b   Libutti, S K ^a   Hwu, P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 8; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; RECEPTOR UPREGULATION; T LYMPHOCYTE; TARGET CELL; TUMOR GROWTH; TUMOR VASCULARIZATION; UMBILICAL VEIN;

ANTIGENS, CD28; CELL ADHESION; CELL LINE; CELLS, CULTURED; CYTOKINES; E-SELECTIN; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; HUMANS; INTERLEUKIN-8; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN STRUCTURE, TERTIARY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, FC; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; UMBILICAL VEINS; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0034634865     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050207939     Document Type: Article

References (36)

1. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
2. Human chemokines: An update
3. The biology of granulocyte-macrophage colony-stimulating factor: Effects on hematopoietic and non-hematopoietic cells
4. Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes
5. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
6. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
7. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
8. Recognition of human colon cancer by T cells transduced with a chimeric receptor gene
9. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
10. Vascular endothelial growth factor and its receptors in normal human testicular tissue
11. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro
12. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
13. 'Diabodies': Small bivalent and bispecific antibody fragments
14. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes
15. Leukocyte migration and adhesion
16. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
17. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sFlt in cycling human endometrium
18. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
19. Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2
20. Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies
21. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
22. Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells
23. Paracrine cytokine adjuvants in cancer immunotherapy
24. Alpha v integrins as receptors for tumor targeting by circulating ligands
25. Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factors to tumor vasculature
26. Antigen processing. Proteasomes in the pathway
27. In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2
28. Expression of vascular endothelial growth factor at the human gastric ulcer margin and in cultured gastric fibroblasts: A new angiogenic factor for gastric ulcer healing
29. Identification of a new endothelial cell growth factor receptor tyrosine kinase
30. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
31. Interleukin-2-transduced lymphocytes growth in an autocrine fashion and remain responsive to antigen
32. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
33. Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lyric capacity
34. Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus
35. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library
36. KDR receptor: A key marker defining hematopoietic stem cells